DFM Funding Monitor

Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancerbroad

PACT4EYE · Horizon Europe grant · 2023-11-01–2026-10-31

EC contribution

€2,499,999

Total cost

€2,499,999

Beneficiaries

4

About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-TRANSITION-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2023-TRANSITIONOPEN-01. CORDIS record →

Objective

Uveal melanoma (UM) is a rare tumor of the eye

Beneficiaries (4)

Organisation	Country	Role	EC contribution	SME
UNIVERSITEIT LEIDEN	NL	coordinator	€1,021,624
RECORNEA SRL	IT	participant	€534,625	Yes
ACADEMISCH ZIEKENHUIS LEIDEN	NL	participant	€471,875
INSTITUT CURIE	FR	participant	€471,875

Get the DFM funding briefing — free

New EU defence calls, tenders and awards in your inbox.

Countries

Germany France Poland Spain Italy

Sectors

Security equipment Military vehicles Weapons & ammunition Military aircraft Warships & naval Military electronics

Sources

calls tenders awards research

I agree to receive the DFM Analysis briefing and funding alerts by email. I can unsubscribe at any time.

Website

Subscribe free

We store your email only to send the DFM briefing/alerts and to add you to DFM Analysis. Unsubscribe anytime.

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.